Chao Yu

2.7k total citations
72 papers, 2.0k citations indexed

About

Chao Yu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chao Yu has authored 72 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 33 papers in Cancer Research and 18 papers in Oncology. Recurrent topics in Chao Yu's work include MicroRNA in disease regulation (21 papers), RNA modifications and cancer (12 papers) and Cancer-related molecular mechanisms research (10 papers). Chao Yu is often cited by papers focused on MicroRNA in disease regulation (21 papers), RNA modifications and cancer (12 papers) and Cancer-related molecular mechanisms research (10 papers). Chao Yu collaborates with scholars based in China, Canada and United States. Chao Yu's co-authors include Jianxin Jiang, Chengyi Sun, Chengyi Sun, Meiyuan Chen, Wenyi Qin, Yu Zhong, Zhiwei He, Ling Chen, Lei Zhan and Xingjun Guo and has published in prestigious journals such as Biomaterials, Biochemical and Biophysical Research Communications and Molecular Cancer.

In The Last Decade

Chao Yu

69 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chao Yu China 29 1.3k 992 408 227 188 72 2.0k
Jundong Zhou China 25 1.2k 0.9× 713 0.7× 386 0.9× 193 0.9× 215 1.1× 78 1.9k
Ye Cheng China 19 1.2k 0.9× 650 0.7× 283 0.7× 275 1.2× 262 1.4× 59 2.1k
Amir Reza Aref United States 25 1.4k 1.0× 914 0.9× 309 0.8× 149 0.7× 191 1.0× 50 2.0k
Xiaoli Wu China 30 1.8k 1.4× 741 0.7× 438 1.1× 181 0.8× 206 1.1× 82 2.8k
Xingwu Wang China 19 1.6k 1.2× 1.4k 1.4× 459 1.1× 135 0.6× 210 1.1× 35 2.4k
Wenchao Liu China 27 1.3k 1.0× 566 0.6× 451 1.1× 327 1.4× 271 1.4× 77 2.1k
Yugang Wang China 24 1.1k 0.8× 680 0.7× 307 0.8× 231 1.0× 169 0.9× 43 1.8k
Wei Xiao China 25 1.2k 1.0× 968 1.0× 383 0.9× 147 0.6× 231 1.2× 44 1.9k
Liang Chu China 27 1.5k 1.1× 638 0.6× 385 0.9× 145 0.6× 112 0.6× 65 2.2k
Jianxin Jiang China 34 1.8k 1.4× 1.3k 1.3× 586 1.4× 254 1.1× 197 1.0× 99 2.6k

Countries citing papers authored by Chao Yu

Since Specialization
Citations

This map shows the geographic impact of Chao Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao Yu more than expected).

Fields of papers citing papers by Chao Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chao Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao Yu. The network helps show where Chao Yu may publish in the future.

Co-authorship network of co-authors of Chao Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Chao Yu. A scholar is included among the top collaborators of Chao Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chao Yu. Chao Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Lingling, Li Liang, Chao Yu, et al.. (2025). Hsa_circ_0007991 Promotes Immune Evasion in Hepatocellular Carcinoma via Regulation of the miR-505-3p/CANX Axis. Journal of Hepatocellular Carcinoma. Volume 12. 1337–1351.
3.
El‐Serafi, Ibrahim, Sofia Berglund, Alina Codita, et al.. (2025). Mechanisms underlying seizures and hypothermia during busulphan administration. Bone Marrow Transplantation. 60(8). 1120–1128.
4.
Yu, Chao, et al.. (2024). Long non-coding RNA MIAT serves as a biomarker of fragility fracture and promotes fracture healing. Journal of Orthopaedic Surgery and Research. 19(1). 343–343. 6 indexed citations
5.
6.
7.
Yu, Chao, et al.. (2022). The Senescence‐Related Signature Predicts Prognosis and Characterization of Tumor Microenvironment Infiltration in Pancreatic Cancer. BioMed Research International. 2022(1). 1916787–1916787. 3 indexed citations
8.
Jiang, Jianxin, Chao Yu, Xingjun Guo, et al.. (2020). G Protein-Coupled Receptor GPR87 Promotes the Expansion of PDA Stem Cells through Activating JAK2/STAT3. Molecular Therapy — Oncolytics. 17. 384–393. 12 indexed citations
9.
Zhang, Xiangyu, et al.. (2020). <p>Quercetin Enhanced Paclitaxel Therapeutic Effects Towards PC-3 Prostate Cancer Through ER Stress Induction and ROS Production</p>. OncoTargets and Therapy. Volume 13. 513–523. 80 indexed citations
10.
He, Zhiwei, Xingjun Guo, Changhao Zhu, et al.. (2019). MicroRNA-137 reduces stemness features of pancreatic cancer cells by targeting KLF12. Journal of Experimental & Clinical Cancer Research. 38(1). 126–126. 47 indexed citations
11.
Chen, Zili, Yifei Ma, Shi Zuo, et al.. (2019). <p>Long Noncoding RNA RP5-833A20.1 Suppresses Tumorigenesis In Hepatocellular Carcinoma Through Akt/ERK Pathway By Targeting miR-18a-5p</p>. OncoTargets and Therapy. Volume 12. 10717–10726. 7 indexed citations
12.
Yu, Chao, Bo Zhang, Yali Li, & Xiaorui Yu. (2018). SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma. Biomedicine & Pharmacotherapy. 105. 10–17. 33 indexed citations
13.
Zhang, Bo, et al.. (2018). Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma. Biomedicine & Pharmacotherapy. 105. 1–9. 36 indexed citations
14.
Yu, Chao, et al.. (2018). Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway. Theranostics. 8(12). 3224–3236. 81 indexed citations
15.
Yu, Chao, et al.. (2017). Suppression of TAFI by siRNA inhibits invasion and migration of breast cancer cells. Molecular Medicine Reports. 16(3). 3469–3474. 6 indexed citations
16.
Qin, Wenyi, et al.. (2017). miR-142 inhibits the migration and invasion of glioma by targeting Rac1. Oncology Reports. 38(3). 1543–1550. 18 indexed citations
17.
Dai, Xiaomeng, Jun Xue, Jianli Hu, et al.. (2017). Positive Expression of Programmed Death Ligand 1 in Peritumoral Liver Tissue is Associated with Poor Survival after Curative Resection of Hepatocellular Carcinoma. Translational Oncology. 10(4). 511–517. 44 indexed citations
18.
Hu, Jianli, et al.. (2015). Hepatitis B virus induces hypoxia-inducible factor-2α expression through hepatitis B virus X protein. Oncology Reports. 35(3). 1443–1448. 17 indexed citations
19.
Jiang, Jianxin, et al.. (2014). MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer. Cancer Letters. 356(2). 962–970. 59 indexed citations
20.
Liang, Xiaolong, et al.. (2014). miR-101 Inhibits the G1-to-S Phase Transition of Cervical Cancer Cells by Targeting Fos. International Journal of Gynecological Cancer. 24(7). 1165–1172. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jundong Zhou Breakdown of academic impact, for papers by Ye Cheng Breakdown of academic impact, for papers by Amir Reza Aref Breakdown of academic impact, for papers by Xiaoli Wu Breakdown of academic impact, for papers by Xingwu Wang Breakdown of academic impact, for papers by Wenchao Liu Breakdown of academic impact, for papers by Yugang Wang Breakdown of academic impact, for papers by Wei Xiao Breakdown of academic impact, for papers by Liang Chu Breakdown of academic impact, for papers by Jianxin Jiang
Rankless by CCL
2026